Evidence map›Paper›PMID 29966273›Full record

ArticleMolecules (Basel, Switzerland)2018

The Mechanism for siRNA Transmembrane Assisted by PMAL.

Yanfei Lu, Jipeng Li, Nan Su, Diannan Lu

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yanfei LuDepartment of Chemical Engineering, Tsinghua University, Beijing 100084, China. lu511966207@163.com.
Jipeng LiDepartment of Chemical Engineering, Tsinghua University, Beijing 100084, China. lijipeng0927@163.com.
Nan SuDepartment of Chemical Engineering, Tsinghua University, Beijing 100084, China. sunan12345@126.com.
Diannan LuDepartment of Chemical Engineering, Tsinghua University, Beijing 100084, China. ludiannan@tsinghua.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The capacity of silencing genes makes small interfering RNA (siRNA) appealing for curing fatal diseases. However, the naked siRNA is vulnerable to and degraded by endogenous enzymes and is too large and too negatively charged to cross cellular membranes. An effective siRNA carrier, PMAL (poly(maleic anhydride-alt-1-decene) substituted with 3-(dimethylamino) propylamine), has been demonstrated to be able to assist siRNA transmembrane by both experiments and molecular simulation. In the present work, the mechanism of siRNA transmembrane assisted by PMAL was studied using steered molecular dynamics simulations based on the martini coarse-grained model. Here two pulling rates, i.e., 10

Indexed as

PolymersPropylaminesAlgorithmsBiological TransportCell MembraneDrug CarriersGene Transfer TechniquesLipid BilayersModels, BiologicalMolecular Dynamics SimulationRNA, Small InterferingDrug CarriersLipid BilayersPolymersPropylaminesRNA, Small InterferingPMALPMFsiRNAsteered molecular dynamics simulationtransmembrane delivery

Identifiers

PMID29966273
PMCPMC6099945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.